Karin Garre
Direktor/Vorstandsmitglied bei EXPRES2ION BIOTECH HOLDING AB
Profil
Karin Garre is an Independent Director at Expres2ion Biotech Holding AB.
She is also a Director at Cervello A.
Previously, she served as the General Manager at Symphogen A.
Before that, she was the Chief Executive Officer at K:2.
Holding ApS.
She also held the position of Chairman at NTG Nordic Transport Group A from 2013 to 2018.
Additionally, she has experience as a Director at StemCare A, StemCare Danmark A, and Lægernes Test Center A.
Dr. Garre obtained her doctorate degree from the University of Copenhagen in 1983.
Aktive Positionen von Karin Garre
| Unternehmen | Position | Beginn |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Direktor/Vorstandsmitglied | 26.05.2021 |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 05.06.2020 |
| Cervello A/S | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Karin Garre
| Unternehmen | Position | Ende |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Vorsitzender | 14.09.2018 |
| Lægernes Test Center A/S | Direktor/Vorstandsmitglied | - |
| StemCare Danmark A/S | Direktor/Vorstandsmitglied | - |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Direktor/Vorstandsmitglied | - |
| K:2 Holding ApS | Vorstandsvorsitzender | - |
Ausbildung von Karin Garre
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Health Technology |
| StemCare Danmark A/S | |
| K:2 Holding ApS | |
| Lægernes Test Center A/S | |
| Cervello A/S |
